This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Zacks.com featured highlights include: Pilgrim's Pride, Bed Bath & Beyond, Owens Corning, Arthur J. Gallagher & Co. and Valmont Industries
by Zacks Equity Research
Zacks.com featured highlights include: Pilgrim's Pride, Bed Bath & Beyond, Owens Corning, Arthur J. Gallagher & Co. and Valmont Industries
Upgraded Broker Ratings Make These 5 Stocks Worth Buying Now
by Swayta Shah
One way to selecting stocks from the vast investment universe is to follow broker recommendation. Let's check out - Pilgrim's Pride (PPC), Bed Bath & Beyond (BBBY), Owens Corning (OC), Arthur J. Gallagher (AJG) and Valmont Industries (VMI) - as these witness ratings upgrade.
Here is Why Growth Investors Should Buy Arthur J. Gallagher (AJG) Now
by Zacks Equity Research
Arthur J. Gallagher (AJG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Aon's (AON) Q3 Earnings Surpass Estimates, Increase Y/Y
by Zacks Equity Research
Aon's (AON) third-quarter results reflect lower expenses and a solid contribution from its Commercial Risk Solutions and Reinsurance Solutions segments.
Arthur J. Gallagher (AJG) Q3 Earnings & Revenues Top, Up Y/Y
by Zacks Equity Research
Arthur J. Gallagher (AJG) Q3 earnings reflect lower expenses, higher adjusted revenues and strong margin expansion across Brokerage and Risk Management segments.
Arthur J. Gallagher (AJG) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Arthur J. Gallagher (AJG) delivered earnings and revenue surprises of 20.00% and 4.95%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stocks Earnings on Oct 29: MMC, WLTW and More
by Tanuka De
Insurers' third quarter results are likely to have benefited from improved pricing, strong retention, new business, partially offset by cat losses and lower interest rate.
What Awaits Arthur J. Gallagher (AJG) This Earnings Season?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q3 results are likely to reflect new business generation, solid retentions and higher property and casualty rates.
Marsh & McLennan (MMC) to Report Q3 Earnings: What to Expect
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter 2020 results are likely to witness muted revenues.
What's in the Cards for Willis Towers (WLTW) in Q3 Earnings?
by Zacks Equity Research
Willis Towers (WLTW) Q3 earnings are likely to have benefited from higher commissions, net new business, and favorable renewals. However, revenues may have been under pressure due to the COVID-19 pandemic.
Discover Financial's (DFS) Q3 Earnings Beat, Increase Y/Y
by Zacks Equity Research
Discover Financial's (DFS) third-quarter earnings gain from strong sales in September and growth in loan products.
Arthur J. Gallagher (AJG) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Arthur J. Gallagher (AJG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brown & Brown (BRO) Rewards Shareholders With Dividend Hike
by Zacks Equity Research
Brown & Brown's (BRO) recent dividend hike highlights strong financial position and constant efforts to enhance shareholders' value.
Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co
by Zacks Equity Research
Zacks.com featured highlights include: Vertex Pharmaceuticals, PerkinElmer, Stanley Black & Decker, 3M and Arthur J. Gallagher & Co
Bet on These 5 Top-Ranked Stocks With Strong Sales Growth
by Swayta Shah
Robust sales growth is an important characteristic of potential stock market winners. Let's check out - Vertex Pharmaceuticals (VRTX), PerkinElmer (PKI), Stanley Black & Decker (SWK), 3M Company (MMM) and Arthur J. Gallagher (AJG) - as these are likely to see solid sales growth.
Synchrony Financial (SYF) Q3 Earnings Miss Estimates, Down Y/Y
by Zacks Equity Research
Synchrony Financial's (SYF) third-quarter results reflect muted revenues induced by the coronavirus pandemic.
Why Arthur J. Gallagher (AJG) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Arthur J. Gallagher (AJG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
eHealth (EHTH) to Report Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
eHealth's (EHTH) Q3 results are likely to benefit from solid performance at Medicare and individual and family plan business.
Is Arthur J. Gallagher (AJG) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Arthur J. Gallagher (AJG) is well positioned to outperform the market, as it exhibits above-average growth in financials.
All You Need to Know About Arthur J. Gallagher (AJG) Rating Upgrade to Buy
by Zacks Equity Research
Arthur J. Gallagher (AJG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Brown & Brown's Subsidiary Buys Assets of Bright & Associates
by Zacks Equity Research
Brown & Brown's (BRO) subsidiary Brown & Brown Dealer Services acquires Bright & Associates to extend its presence in Missouri and Illinois.
Aon's Board Approves 5% Dividend Hike to Reward Shareholders
by Zacks Equity Research
Aon (AON) proposes 5% dividend raise to share more profits with shareholders, thereby supporting effective capital deployment.
Arch Capital to Buy Watford Holdings in a Cash Transaction
by Zacks Equity Research
Arch Capital (ACGL) will acquire the remaining 87% of Watford Holdings' shares for $622 million or $31.10 per share in cash.
Why Should You Retain Marsh & McLennan in Your Portfolio?
by Zacks Equity Research
Owing to strategic measures and an encouraging solvency position, Marsh & McLennan (MMC) holds enough promises for investors' portfolio.
Arthur J. Gallagher (AJG) Up 10% YTD: More Room for Upside?
by Zacks Equity Research
Solid segmental performances and strategic acquisitions poise Arthur J. Gallagher (AJG) well for growth.